MyLife Technologies

📍 Leiden, Netherlands🗓 Founded 2012👥 11 employees💰 Last funded Jan 2016
Pharmaceutical Manufacturing🌐 mylifetechnologies.nl
Website LinkedIn
MyLife Technologies (Leiden, The Netherlands) develops small ceramic skin patches that deliver vaccines in a much better way than the usual needle injections in muscles. Your skin contains the highest levels of immune cells that handle vaccines to protect you against infections; muscles do not. With our ceramic skin patches we offer vaccine developers and NGO's three main benefits: 1) 5-20x less vaccine needed to achieve sufficient protection and no need for adjuvants. 2) Vaccines in our ceramic skin patches can be shipped and stored at ambient temperatures. 3) Our skin patches never touch a nerve or a blood vessel: no pain, no blood, no needle anxiety... And they are very easy to apply within 30 seconds like any other skin patch. Afterwards they can be discarded as normal waste. These benefits are achieved through our patent protected nano-porous ceramic structure. We tune and tailor the delivery of many different vaccines, including peptides, protein complexes VLP's and mRNA and DNA-vaccines. The company develops improved vaccine delivery as commercial service for vaccine developers and in NGO-partnerships.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
1
Frequently asked questions
Who invested in MyLife Technologies?
MyLife Technologies has 1 investors on record on gritt.io, 1 mid-stage.
When did MyLife Technologies last raise funding?
The most recent investment in MyLife Technologies recorded on gritt.io was in January 2016.
When was MyLife Technologies founded?
MyLife Technologies was founded in 2012.
What industry is MyLife Technologies in?
MyLife Technologies operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is MyLife Technologies based?
MyLife Technologies is headquartered in Leiden, Netherlands.